Serum Clusterin as a Tumor Marker and Prognostic Factor for Patients with Esophageal Cancer

Table 1

Patient characteristics.

Characteristics	Number (%)
Gender
Male	79 (91)
Female	8 (9)
Age (yr)
Median	60
Average	59
Tumor location
Upper	5 (6)
Middle	58 (66)
Lower	25 (28)
Pathological stage
I	13 (15)
II	35 (40)
III	39 (45)
Lymph node yield
Median	21
Average	24